Patents by Inventor Hans Schram

Hans Schram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210338687
    Abstract: The invention relates to an oral dosage form of mifepristone of mifepristone oral formulation characterised in that said formulation comprises an amount selected from the group consisting of 75 mg, 150 mg or 300 mg mifepristone, and said formulation is for its use in the induction of labour and cervix ripening in a woman being at least 37 weeks pregnant.
    Type: Application
    Filed: October 30, 2020
    Publication date: November 4, 2021
    Applicant: DISPHAR INTERNATIONAL BV
    Inventors: Sophie Rolande VAN TOMME, Helene Marie Virginie HERMAN, Hans SCHRAM
  • Patent number: 9511019
    Abstract: A stable and/or synergistic pharmaceutical composition including: a) predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium and b) 5-ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: December 6, 2016
    Assignees: NORDIC PHARMA, DISPHAR INTERNATIONAL BV
    Inventors: Hans Schram, Michael Ikechukwu Ugwoke, Laura Buttafoco
  • Publication number: 20120149667
    Abstract: A stable and/or synergistic pharmaceutical composition including: a) predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium and b) 5-ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration.
    Type: Application
    Filed: August 25, 2010
    Publication date: June 14, 2012
    Applicants: DISPHAR INTERNATIONAL BV, NORDIC PHARMA
    Inventors: Hans Schram, Michael Ikechukwu Ugwoke, Laura Buttafoco